Financials data is unavailable for this security.
View more
Year on year OptiBiotix Health PLC had net income fall from a gain of 2.59m to a loss of 2.04m despite a 40.92% increase in revenues from 457.00k to 644.00k. An increase in the cost of goods sold as a percentage of sales from 46.61% to 50.31% was a component in the falling net income despite rising revenues.
| Gross margin | 47.98% |
|---|---|
| Net profit margin | -524.43% |
| Operating margin | -351.67% |
| Return on assets | -33.25% |
|---|---|
| Return on equity | -36.34% |
| Return on investment | -34.85% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at OptiBiotix Health PLC fell by 417.00k. However, Cash Flow from Investing totalled 1.11m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.53m for operations while cash from financing was breakeven.
| Cash flow per share | -0.0297 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0752 |
|---|---|
| Tangible book value per share | 0.0627 |
More ▼
Balance sheet in GBPView more
| Current ratio | 6.18 |
|---|---|
| Quick ratio | 5.36 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
